MONTE ROSA THERAPEUTICS INC. - COMMON STOCK

Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences

03 фев 2022 16:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics and Yeda, the commercial arm of the Weizmann Institute of Science, Announce License and Research Collaboration to Accelerate Discovery of Novel Covalent Molecular Glue Degraders

25 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer

02 дек 2021 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

22 ноя 2021 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces First Development Candidate and Reports Third Quarter 2021 Financial Results and Business Updates

10 ноя 2021 07:30:01 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation Summit

20 окт 2021 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer

07 окт 2021 09:00:02 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Present Late-breaking Preclinical Data on Targeting GSPT1 for Myc-driven Cancers at AACR-NCI-EORTC Virtual International Conference

30 сен 2021 16:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes

10 сен 2021 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

08 сен 2021 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

12 авг 2021 07:30:00 Источник Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

23 июн 2021 20:20:00 Источник Nasdaq GlobeNewswire